News
Pain after breast surgery may not be caused by the operation
The source of postop pain in breast surgery patients is not well understood.
News
Model validates use of HCV+ livers for transplant
A multi-institutional team of researchers has developed a mathematical model that shows when hepatitis C–positive-to-negative transplant may...
News
C7 nerve transfer shows promising results for spastic arm paralysis
“Exciting” results require “clarification and confirmation.”
News
GERD linked to upper aerodigestive tract cancers in elderly
The increased relative risk for laryngeal and pharyngeal cancers in this population suggests an opportunity for earlier detection and intervention...
News
Clinic eases pediatric-adult transition in sickle cell disease
CONCORD, N.C. – Transitional programs could help teenage patients continue self-care and avoid risk behaviors.
News
Defining quality in lung cancer surgery
Quality initiatives can lead to better outcomes, but can be complex.
News
Bilateral ACP shown similar to unilateral in arch replacement study
Bilateral outperformed unilateral antegrade cerebral perfusion numerically, but not statistically, in several key areas.
News
The Liver Meeting 2017 NAFLD debrief – key abstracts
WASHINGTON – Nonalcoholic fatty liver disease is a complex disease that involves multiple organ systems.
News
Emerging sickle cell agents target new pathways
CONCORD, N.C. – There are a number of new drugs in the sickle cell disease pipeline, and researchers are investigating gene therapy using patients...
News
Dedicated sickle cell center offers roadmap for care
CONCORD, N.C. – The Georgia Comprehensive Sickle Cell Center includes a dedicated emergency room.
News
Study examines intestinal microbiota role post liver transplant
Colonization by multidrug-resistant organisms has a large effect on infections, microbiome diversity, and transplant outcomes.
News
Nivolumab may extend survival in HCC patients
WASHINGTON – About 20% of patients achieved an objective remission that included complete responses in all subgroups of patients.
News
Emerging oral agent reduces ALT in NAFLD
In phase 2 dose-finding study, hepatic fraction decreased in treated patients.
News
Novel metabolite may be key in NAFLD
The gut microbiome–derived metabolite may be a useful biomarker.
News
Hispanics bear brunt of NAFLD disease burden
Relative risk of NAFLD is higher in Hispanics, but the risk of death from NAFLD is highest in whites.